Tumor volume ratio (log10%) in IDH1 WT was significantly increased after bevacizumab treatment than BCAT1 sh#1 rats (2.3210 [IQR, 2.2505–2.6005] vs 2.1370 [1.9173–2.2232]; p = 0.0181) (Figure 3D). This evidence concerns the gene IDH1 and neoplasm.